Utility of Serum and Bronchoalveolar Fluid Urokinase Like Plasminogen Activator Levels in Defining Patients at Higher Risk of Hemoptysis.
This is a prospective observational study looking at some coagulation factors in individuals
with lung cancer. We are looking at BAL and plasma. We would like to see if there is a
difference in the levels and if this is the reason behind the higher incidence of hemoptysis
in patients with lung cancer.
Observational Model: Case Control, Time Perspective: Prospective
Jijo John, MD
University of Oklahoma
United States: Institutional Review Board
|VA Medical Center||Oklahoma City, Oklahoma 73104|